Literature DB >> 15333922

Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B.

Anja K Pedersen1, G üNther H Peters G, Karin B Møller, Lars F Iversen, Jette S Kastrup.   

Abstract

Protein tyrosine phosphatase 1B (PTP1B) plays a key role as a negative regulator of insulin and leptin signalling and is therefore considered to be an important molecular target for the treatment of type 2 diabetes and obesity. Detailed structural information about the structure of PTP1B, including the conformation and flexibility of active-site residues as well as the water-molecule network, is a key issue in understanding ligand binding and enzyme kinetics and in structure-based drug design. A 1.95 A apo PTP1B structure has been obtained, showing four highly coordinated water molecules in the active-site pocket of the enzyme; hence, the active site is highly solvated in the apo state. Three of the water molecules are located at positions that approximately correspond to the positions of the phosphate O atoms of the natural substrate phosphotyrosine and form a similar network of hydrogen bonds. The active-site WPD-loop was found to be in the closed conformation, in contrast to previous observations of wild-type PTPs in the apo state, in which the WPD-loop is open. The closed conformation is stabilized by a network of hydrogen bonds. These results provide new insights into and understanding of the active site of PTP1B and form a novel basis for structure-based inhibitor design.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15333922     DOI: 10.1107/S0907444904015094

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  20 in total

1.  Visualizing active-site dynamics in single crystals of HePTP: opening of the WPD loop involves coordinated movement of the E loop.

Authors:  David A Critton; Lutz Tautz; Rebecca Page
Journal:  J Mol Biol       Date:  2010-11-19       Impact factor: 5.469

2.  Conformational basis for substrate recruitment in protein tyrosine phosphatase 10D.

Authors:  Lalima L Madan; B Gopal
Journal:  Biochemistry       Date:  2011-10-27       Impact factor: 3.162

3.  Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases.

Authors:  Cynthia M Chio; Xiaoling Yu; Anthony C Bishop
Journal:  Bioorg Med Chem       Date:  2015-03-17       Impact factor: 3.641

4.  Water-mediated ionic interactions in protein structures.

Authors:  R Sabarinathan; K Aishwarya; R Sarani; M Kirti Vaishnavi; K Sekar
Journal:  J Biosci       Date:  2011-06       Impact factor: 1.826

5.  Insights into the reaction of protein-tyrosine phosphatase 1B: crystal structures for transition state analogs of both catalytic steps.

Authors:  Tiago A S Brandão; Alvan C Hengge; Sean J Johnson
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

6.  Inactivation of protein tyrosine phosphatases by oltipraz and other cancer chemopreventive 1,2-dithiole-3-thiones.

Authors:  Sanjib Bhattacharyya; Haiying Zhou; Derrick R Seiner; Kent S Gates
Journal:  Bioorg Med Chem       Date:  2010-06-30       Impact factor: 3.641

7.  Impaired acid catalysis by mutation of a protein loop hinge residue in a YopH mutant revealed by crystal structures.

Authors:  Tiago A S Brandão; Howard Robinson; Sean J Johnson; Alvan C Hengge
Journal:  J Am Chem Soc       Date:  2009-01-21       Impact factor: 15.419

Review 8.  Using NMR spectroscopy to elucidate the role of molecular motions in enzyme function.

Authors:  George P Lisi; J Patrick Loria
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2015-12-07       Impact factor: 9.795

9.  Hyperconjugation-mediated solvent effects in phosphoanhydride bonds.

Authors:  Jean C Summerton; Jeffrey D Evanseck; Michael S Chapman
Journal:  J Phys Chem A       Date:  2012-10-09       Impact factor: 2.781

10.  Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery.

Authors:  Katie R Martin; Pooja Narang; José L Medina-Franco; Nathalie Meurice; Jeffrey P MacKeigan
Journal:  Methods       Date:  2013-08-20       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.